Form 4: Pulmonx Corp Director Tiffany Sullivan Reports Changes in Beneficial Ownership

Director Tiffany Sullivan reports acquisition and disposal of Pulmonx Corp common stock on June 3, 2024, according to a Form 4 filing.

Summary

• On June 3, 2024, Tiffany Sullivan, a director of Pulmonx Corp, reported changes in beneficial ownership of the company's common stock.
• Sullivan acquired 15,216 shares of common stock through a Restricted Stock Unit (RSU) grant.
• The RSU grant vests on the earlier of June 3, 2025 (or the next business day if that date is not a business day), or the date of the Annual Meeting of Stockholders for the year subsequent to the grant date.
• Sullivan also disposed of 15,216 shares.
• Following these transactions, Sullivan beneficially owns 38,046 shares of Pulmonx Corp common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Positives

• The RSU grant to a director could be seen as an incentive aligning their interests with the company's success.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions and doesn't provide specific insights into the broader medical device industry or Pulmonx's competitive positioning.

Stakeholder Impact

• The transaction may have a minor impact on shareholders as it reflects insider activity, but the overall effect is likely minimal.

Key Dates